Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific to Distribute Response Bio's Ramp Cardiac Product in Canada

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fisher Scientific will exclusively distribute Response Biomedical's RAMP cardiac products in Canada under a deal announced today.

Financial and other terms of the agreement were not disclosed.

Fisher Scientific is part of Thermo Fisher Scientific.

According to Vancouver, British Columbia-based Response Biomedical, point-of-care testing in Canada is projected to reach C$63 million ($66.2 million) this year with an estimated growth rate of 7 percent over the next few years.

Response Bio's RAMP system consists of a reader and single-use disposable test cartridges. RAMP clinical tests are commercially available for the early detection of heart attack and congestive heart failure.